PATENT CLAIM ANALYSIS

Application Number: 15945285
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["549", "200000"]

Abstract:
The present disclosure generally provides compounds useful for treating cancer. In some aspects, the disclosure provides small-molecule cytotoxins that are chemically modified to include one or more moieties that include hydrophobic portions. In some embodiments, the disclosure provides small-molecule cytotoxins that are chemically modified with fatty acid-containing moieties. In some aspects, the disclosure provides compositions, such as pharmaceutical compositions, that include such modified small-molecule cytotoxins and a protein. In some embodiments, the protein is albumin or an albumin mimetic. Further, the disclosure provides various uses of these compounds and compositions.

Claim (Index 48):
The compound of  claim 48 , wherein the paclitaxel moiety is a moiety of the formula:

Metadata:
- Claim Count in Document: 152.0
- Percentile: 91.0
- Lexical Diversity: 2.06
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15466819', '15737247', '14298952', '11978122', '15335164']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7019723854257461
- 35 USC 102 Novelty (BERT): 0.5382643683992506
- Combined Prediction Score: 0.6856015837230965
- Mean Citation Score: 224.077398
- Max Citation Score: 372.22952
- Similarity Product: 289.1743955067825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test